ReviewSeminars in immunopathology2008
NOX enzymes as novel targets for drug development.
J David Lambeth et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
100 papers cite itlatest 60 shown
this papercites it
ReviewSeminars in immunopathology2008
J David Lambeth et al.PubMed ↗Publisher ↗
No numbers read from the abstract.